1.
Hind A. Alnajashi, Foziah Alshamrani,. Progressive Multifocal Leukoencephalopathy Risk Mitigation: A Focus on Approved Immunomodulatory Drugs for Multiple Sclerosis Treatment. JKAU Med Sci [Internet]. 2020 Dec. 31 [cited 2024 Nov. 24];27(2):33-44. Available from: https://journals.kau.edu.sa/index.php/MedSci/article/view/883